Quantbot Technologies’s Concert Pharmaceuticals, Inc. CNCE Stock Holding History

Quantbot Technologies’s Portfolio CNCE Stock Details CNCE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q4	–	Sell	-1,034	Closed	-$3K	–	2041
2021 Q3	$3K	Hold	1,034	–	–	﹤0.01%	1435
2021 Q2	$4K	Buy	+1,034	New	+$4.38K	﹤0.01%	1383
2021 Q1	–	Sell	-500	Closed	-$6K	–	1867
2020 Q4	$6K	Buy	+500	New	+$5.7K	﹤0.01%	1154
2018 Q4	–	Sell	-3,545	Closed	-$52K	–	1524
2018 Q3	$52K	Buy	3,545 +1,255	+55%	+$19.7K	﹤0.01%	1039
2018 Q2	$38K	Buy	+2,290	New	+$44.5K	﹤0.01%	1031
2018 Q1	–	Sell	-6,608	Closed	-$170K	–	1593
2017 Q4	$170K	Buy	+6,608	New	+$133K	0.02%	738
2017 Q2	–	Sell	-8,131	Closed	-$138K	–	1464
2017 Q1	$138K	Buy	+8,131	New	+$97.5K	0.01%	720

Other funds holding CNCE

RCM

RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return

BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return

Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return

ISL

Ingalls & Snyder LLC New York $2.83B AUM 21.61% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Quantbot Technologies's CNCE Position: Q4 2021 in Review

Quantbot Technologies sold out of Concert Pharmaceuticals, Inc. (CNCE) in Q4 2021, closing a stake of 1,034 shares — an estimated $3K sold.

Quantbot Technologies first reported a position in CNCE in Q1 2017 and held it in 7 quarters. The position peaked at $170K in Q4 2017. 52 funds tracked by Wall St. Rank hold CNCE as of Q4 2021.

Quantbot Technologies reported no remaining Concert Pharmaceuticals, Inc. position as of Q4 2021 after selling out during the quarter.
Quantbot Technologies sold 1,034 Concert Pharmaceuticals, Inc. shares in Q4 2021, an estimated $3K.
Quantbot Technologies first reported a position in Concert Pharmaceuticals, Inc. in Q1 2017 and held it in 7 quarters.
Quantbot Technologies's Concert Pharmaceuticals, Inc. position peaked at $170K in Q4 2017.
52 funds tracked by Wall St. Rank held Concert Pharmaceuticals, Inc. as of Q4 2021.

Based on Quantbot Technologies's 13F filing for Q4 2021, filed 11 Feb 2022.